“Sputum as a Diagnostic Tool for the Treatment of Asthma” American Academy of Allergy, Asthma and Immunology (AAAAI) 2026 Annual Meeting March 1, 2026 Authors R. Titone, D.A. Porraz, D.W. Putnam, R.P. Jacob, W.E. Bauta and D.J. Elzi

Academy of Allergy, Asthma and Immunology (AAAAI) 2026 Annual Meeting March 1, 2026 Authors: R. Titone, D.A. Porraz, D.W. Putnam, R.P. Jacob, W.E. Bauta and D.J. Elzi. Background: Asthma is a heterogeneous disease with multiple clinical phenotypes and endotypes,1 each...

bioAffinity Technologies Announces Validation Study with Brooke Army Medical Center to Expand Sample Collection Options for the CyPath® Lung Noninvasive Early Detection Lung Cancer Test

Validating sample collection by deep suction has potential to accelerate and expand adoption of CyPath® Lung SAN ANTONIO, TX – February 25, 2026 – bioAffinity Technologies, Inc. (Nasdaq: BIAF; BIAFW), a biotechnology company focused on noninvasive diagnostics and...